000 01644 a2200469 4500
005 20250516015217.0
264 0 _c20120403
008 201204s 0 0 eng d
022 _a1916-7245
024 7 _a10.1155/2010/686098
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMittoo, Shikha
245 0 0 _aTreatment of pulmonary hypertension in patients with connective tissue disease and interstitial lung disease.
_h[electronic resource]
260 _bCanadian respiratory journal
_c
300 _a282-6 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAntihypertensive Agents
_xtherapeutic use
650 0 4 _aBosentan
650 0 4 _aConnective Tissue Diseases
_xcomplications
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aHypertension, Pulmonary
_xdrug therapy
650 0 4 _aKaplan-Meier Estimate
650 0 4 _aLung Diseases, Interstitial
_xcomplications
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPhosphodiesterase 5 Inhibitors
_xtherapeutic use
650 0 4 _aPiperazines
_xtherapeutic use
650 0 4 _aPurines
_xtherapeutic use
650 0 4 _aRespiratory Function Tests
650 0 4 _aRetrospective Studies
650 0 4 _aSildenafil Citrate
650 0 4 _aSulfonamides
_xtherapeutic use
650 0 4 _aSulfones
_xtherapeutic use
700 1 _aJacob, Thomas
700 1 _aCraig, Andrea
700 1 _aBshouty, Zoheir
773 0 _tCanadian respiratory journal
_gvol. 17
_gno. 6
_gp. 282-6
856 4 0 _uhttps://doi.org/10.1155/2010/686098
_zAvailable from publisher's website
999 _c20454144
_d20454144